Allerkast is recommended to be administered to children aged 15+.
No well controlled trials have been performed with either Montelukast or Levocetirizine in women who are pregnant. Therefore, use of Montelukast plus Levocetirizine is not recommended in women who are pregnant.
Some patients do experience somnolence, fatigue and asthenia under therapy with Levocetirizine. Therefore, patients intending to drive, engage in potentially hazardous activities or operate machinery should take their response to the medicinal product into account.